Answers are grounded in this paper and cite their sources.
The kinetics of the oxidation of hydroquinone (H(2)Q) and its derivatives (H(2)Q-X) by trans-[Ru(VI)(tmc)(O)(2)](2+) (tmc = 1,4,8,11-tetramethyl-1,4,8,11-tetraazacyclotetradecane) have been studied in aqueous acidic solutions and in acetonitrile. In H(2)O, the oxidation of H(2)Q has the following stoichiometry: trans-[Ru(VI)(tmc)(O)(2)](2+) + H(2)Q --> trans-[Ru(IV)(tmc)(O)(OH(2))](2+) + Q. The reaction is first order in both Ru(VI) and H(2)Q, and parallel pathways involving the oxidation of H(2)Q and HQ(-) are involved. The kinetic isotope effects are k(H(2)O)/k(D(2)O) = 4.9 and 1.2 at pH = 1.79 and 4.60, respectively. In CH(3)CN, the reaction occurs in two steps, the reduction of trans-[Ru(VI)(tmc)(O)(2)](2+) by 1 equiv of H(2)Q to trans-[Ru(IV)(tmc)(O)(CH(3)CN)](2+), followed by further reduction by another 1 equiv of H(2)Q to trans-[Ru(II)(tmc)(CH(3)CN)(2)](2+). Linear correlations between log(rate constant) at 298.0 K and the O-H bond dissociation energy of H(2)Q-X were obtained for reactions in both H(2)O and CH(3)CN, consistent with a H-atom transfer (HAT) mechanism. Plots of log(rate constant) against log(equilibrium constant) were also linear for these HAT reactions.
No takes yet. Share an insight, caveat, or question.
Lam et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: